May 11, 2007 / 4:17 PM / 10 years ago

Targanta Therapeutics files with SEC to go public

1 Min Read

WASHINGTON, May 11 (Reuters) - Biopharmaceutical company Targanta Therapeutics Corp. filed with regulators on Friday to raise up to $86.25 million in an initial public offering of common stock.

The Cambridge, Massachusetts-based company, which develops antibiotics for serious infections treated or acquired in hospitals, said Credit Suisse, Cowen and Co., Lazard Capital Markets, and Leerink Swann & Co. are underwriting the IPO.

The company did not reveal in the preliminary prospectus with the U.S. Securities and Exchange Commission the number of shares it expects to sell or the expected price of the shares.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below